ABB-N 0 ROK-N 5.41 SIEGY-OTC 0 NVDA-Q 3.82 BAC-N 0.43 MSCI-N -5.07 GRBK-Q 0.23
Daily Stock Opinions and Ratings
The ultimate 360° Tracker Your financial life in one place, automatically
Stockchase Opinions

Jim Cramer - Mad Money Sorrento Therapeutics SRNE-Q RISKY Mar 22, 2021

A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$9.840

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Sorrento Therapeutics(SRNE-Q)

Jun 30, 2021
Not a meme stock but it has too much hot money in it.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$9.690

Stock price when the opinion was issued

biotechnology

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

ISRG-Q 9.19$487.93
TRI-T 0.82$252.68
ANET-N 2.09$70.76
GS-N 9.32$529.31
PAYC-N 7.71$219.23

Today's Top Picks

ABB-N 0$50.68
ROK-N 5.41$239.83
SIEGY-… 0$109.48
NVDA-Q 3.82$102.71
BAC-N 0.43$38.75

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

CAT-N 4.6$295.77
BCE-T 0.07$30.84
KHC-Q -0.11$30.09
ECN-T 0.09$2.84
DHI-N -0.17$124.79

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Paul Harris, CFA

Harris Douglas Asset Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

© Stockchase Inc.